Brain Tumor Diagnosis and Treatment Market - Global Industry Analysis

Brain Tumor Diagnosis and Treatment Market By Diagnosis (MRI, CT Scan, PET-CT Scan, EEG, Molecular Testing, and Others). By Treatment (Surgery, Radiation Therapy, Radiosurgery, Chemotherapy, Targeted Drug Therapy, and Immunotherapy). By Product Type (Primary Brain Tumor and Secondary Brain Tumor). and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2022-2028

Published Date: 10-May-2022 Category: Healthcare Report Format : PDF Pages: 168 Report Code: ZMR-3468 Status : Published

The Brain Tumor Diagnosis and Treatment Market was worth around USD 1,395.7 million in 2021 and is estimated to grow to about USD 2,036.5 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.5 percent over the forecast period.

Description

Industry Prospective:

The Brain Tumor Diagnosis and Treatment Market was worth around USD 1,395.7 million in 2021 and is estimated to grow to about USD 2,036.5 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.5 percent over the forecast period. The report analyzes the Brain Tumor Diagnosis and Treatment Market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Brain Tumor Diagnosis and Treatment Market.

Brain Tumor Diagnosis and Treatment Market: Overview

When abnormal cells develop within the brain, they produce a brain tumor. The growing geriatric population and increased prevalence of brain tumors are significant factors driving the global growth of the brain tumor diagnosis and treatment market. Additionally, the increasing number of technical developments, as well as rising levels of investment in research and development activities, would contribute to the expansion of the brain tumor diagnosis and treatment market during the anticipated period. The growing burden of brain tumors increased awareness, and increased R&D on cancer therapies all contribute to the expansion. Rising R&D initiatives to develop immunotherapeutics to treat brain cancers, as well as ongoing government support to develop new therapies, are expected to drive segment growth throughout the projection period. Moreover, government measures to improve healthcare infrastructure, together with joint efforts by pharmaceutical companies to raise knowledge about the availability of various medications, are likely to fuel market expansion throughout the projection period.

Covid-19 Impact

The COVID-19 epidemic has had a favorable influence on the global market for brain tumor treatments. In the case of COVID-19, various sectors have observed an upsurge in drug demand. Pharmaceutical businesses in this sector have greatly improved their supply chain management, boosted their R&D capabilities, and invested more in manufacturing management and quality control. Other major players have observed a similar brain tumor medicine sales scenario. They observed an increase in global demand for oncology medications. Market participants have responded to the rising demand for cancer medications caused by the global COVID-19 pandemic.

Global Brain Tumor Diagnosis and Treatment Market

Brain Tumor Diagnosis and Treatment Market: Driver

Product Demand will be driven by the Rising Incidence and Prevalence of Neurological Disorders

The rapidly increasing frequency of neurological illnesses in adults and children around the world is fuelling market expansion. Brain illnesses, which include psychiatric, developmental, and neurodegenerative diseases, are a growing cause of morbidity worldwide. This can be attributable partly to the growing geriatric population. According to the American Medical Association (AMA), by 2050, more than 20% of the world population would be over the age of 65. Furthermore, by 2030, at least 60% of those aged 65 and up will be living with more than one chronic illness. As a result, the increased prevalence of various neurological disorders worldwide is a major driver driving the growth of the brain tumor medications market.

Brain Tumor Diagnosis and Treatment Market: Restraint

The Increasing Use of Targeted Therapies Will Restriction Market Growth

The increasing use of tailored medicines will be a big impediment. Cancer medications that target cancer cells without hurting normal cells are known as targeted therapies. When compared to traditional chemotherapy and radiation therapy procedures, targeted therapy has proven to be more effective and has fewer side effects. As a result, the growing adoption of these therapies is predicted to disrupt the revenue generated by traditional brain tumor medications, hampering the market's expansion over the forecast period.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Brain Tumor Diagnosis and Treatment Market: Segmentation

The Brain Tumor Diagnosis and Treatment Market are segregated based on Diagnosis, Treatment, and Product Type.

By Diagnosis, the market is classified into MRI, CT Scan, PET-CT Scan, EEG, Molecular Testing, and Others. It has been highlighted that CT-Scans continue to be the most recommended method of brain cancer diagnosis, owing to their capacity to accurately discern between bone masses and elaborate soft tissues, as well as the possibility to capture 3D images in a series from several angles. Furthermore, future technical improvements in new mobile CT-Scan devices are projected to contribute to the growth of the CT-Scan diagnosis segment throughout the forecast period.

By Treatment, the market is classified into Surgery, Radiation Therapy, Radiosurgery, Chemotherapy, Targeted Drug Therapy, and Immunotherapy. The Immunotherapy Market is expected to expand rapidly. Immunotherapy is a method of treating disease by either activating or inhibiting the immune system. Vaccines are an exciting new type of immunotherapy that activates the immune system to combat cancer. Immunotherapy has been shown to be beneficial in the treatment of glioblastoma multiforme, the most common primary malignant brain tumor in adults. Thus, increased R&D initiatives to develop immunotherapeutics to treat brain tumors, as well as ongoing government support to develop chance therapies, are expected to boost industry expansion throughout the projection period.

Recent Developments

  • In 2020, With the approval of an experimental new drug application, Berubicin's producer will be able to begin testing the investigational medicine in people with glioblastoma who have already failed their first treatment.

Regional Landscape

The market for brain tumor diagnostics and therapy is dominated by North America. This region's dominance in this market can be attributed to the greater diagnostic rate of malignancies such as glioblastoma in the United States. Greater access to advanced therapy is also expected to contribute to the region's supremacy. Another important aspect influencing the regional market's expansion is the frequent introduction of new goods, paired with the region's strong presence of significant companies.

Europe will hold the second-largest market share in the forecast period, due to increased R&D funding and investments in the development of novel brain cancer drugs. This, together with vigorous government initiatives to raise awareness and access to brain tumor treatment, is expected to drive the growth of the brain tumor market throughout the forecast period. In addition, increased demand for oncology medications, rising brain cancer prevalence, and an aging population is driving the regional market.

Competitive Landscape

Some of the main competitors dominating the Brain Tumor Diagnosis and Treatment Market include - GE Healthcare, Merck & Co., Inc., AstraZeneca, Carestream Health, Philips Healthcare, Siemens Healthcare Private Limited, Shimadzu Corporation, Hitachi Medical Systems, Pfizer.Inc, and Toshiba Medical Systems.

Brain Tumor Diagnosis and Treatment Market is segmented as follows:

By Diagnosis Type

  • MRI
  • CT Scan
  • PET-CT Scan
  • EEG
  • Molecular Testing
  • Others

By Treatment Type

  • Surgery
  • Radiation Therapy
  • Radiosurgery
  • Chemotherapy
  • Targeted Drug Therapy
  • Immunotherapy

By Product Type

  • Primary Brain Tumor
  • Secondary Brain Tumor

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Brain Tumor Diagnosis and Treatment Market, (2022 - 2028) (USD Million)
    • 2.2 Global Brain Tumor Diagnosis and Treatment Market : snapshot
  • Chapter 3. Global Brain Tumor Diagnosis and Treatment Market - Industry Analysis
    • 3.1 Brain Tumor Diagnosis and Treatment Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Product Demand will be driven by the Rising Incidence and Prevalence of Neurological Disorders
    • 3.3 Market Restraints
      • 3.3.1. The Increasing Use of Targeted Therapies Will Restriction Market Growth
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Diagnosis Type
      • 3.7.2 Market attractiveness analysis By Treatment Type
      • 3.7.3 Market attractiveness analysis By Product Type
  • Chapter 4. Global Brain Tumor Diagnosis and Treatment Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Brain Tumor Diagnosis and Treatment Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Brain Tumor Diagnosis and Treatment Market - Diagnosis Type Analysis
    • 5.1 Global Brain Tumor Diagnosis and Treatment Market overview: By Diagnosis Type
      • 5.1.1 Global Brain Tumor Diagnosis and Treatment Market share, By Diagnosis Type, 2021 and 2028
    • 5.2 MRI
      • 5.2.1 Global Brain Tumor Diagnosis and Treatment Market by MRI, 2022 - 2028 (USD Million)
    • 5.3 CT Scan
      • 5.3.1 Global Brain Tumor Diagnosis and Treatment Market by CT Scan, 2022 - 2028 (USD Million)
    • 5.4 PET-CT Scan
      • 5.4.1 Global Brain Tumor Diagnosis and Treatment Market by PET-CT Scan, 2022 - 2028 (USD Million)
    • 5.5 EEG
      • 5.5.1 Global Brain Tumor Diagnosis and Treatment Market by EEG, 2022 - 2028 (USD Million)
    • 5.6 Molecular Testing
      • 5.6.1 Global Brain Tumor Diagnosis and Treatment Market by Molecular Testing, 2022 - 2028 (USD Million)
    • 5.7 Others
      • 5.7.1 Global Brain Tumor Diagnosis and Treatment Market by Others, 2022 - 2028 (USD Million)
  • Chapter 6. Global Brain Tumor Diagnosis and Treatment Market - Treatment Type Analysis
    • 6.1 Global Brain Tumor Diagnosis and Treatment Market overview: By Treatment Type
      • 6.1.1 Global Brain Tumor Diagnosis and Treatment Market share, By Treatment Type, 2021 and 2028
    • 6.2 Surgery
      • 6.2.1 Global Brain Tumor Diagnosis and Treatment Market by Surgery, 2022 - 2028 (USD Million)
    • 6.3 Radiation Therapy
      • 6.3.1 Global Brain Tumor Diagnosis and Treatment Market by Radiation Therapy, 2022 - 2028 (USD Million)
    • 6.4 Radiosurgery
      • 6.4.1 Global Brain Tumor Diagnosis and Treatment Market by Radiosurgery, 2022 - 2028 (USD Million)
    • 6.5 Chemotherapy
      • 6.5.1 Global Brain Tumor Diagnosis and Treatment Market by Chemotherapy, 2022 - 2028 (USD Million)
    • 6.6 Targeted Drug Therapy
      • 6.6.1 Global Brain Tumor Diagnosis and Treatment Market by Targeted Drug Therapy, 2022 - 2028 (USD Million)
    • 6.7 Immunotherapy
      • 6.7.1 Global Brain Tumor Diagnosis and Treatment Market by Immunotherapy, 2022 - 2028 (USD Million)
  • Chapter 7. Global Brain Tumor Diagnosis and Treatment Market - Product Type Analysis
    • 7.1 Global Brain Tumor Diagnosis and Treatment Market overview: By Product Type
      • 7.1.1 Global Brain Tumor Diagnosis and Treatment Market share, By Product Type, 2021 and 2028
    • 7.2 Primary Brain Tumor
      • 7.2.1 Global Brain Tumor Diagnosis and Treatment Market by Primary Brain Tumor, 2022 - 2028 (USD Million)
    • 7.3 Secondary Brain Tumor
      • 7.3.1 Global Brain Tumor Diagnosis and Treatment Market by Secondary Brain Tumor, 2022 - 2028 (USD Million)
  • Chapter 8. Brain Tumor Diagnosis and Treatment Market - Regional Analysis
    • 8.1 Global Brain Tumor Diagnosis and Treatment Market Regional Overview
    • 8.2 Global Brain Tumor Diagnosis and Treatment Market Share, by Region, 2021 & 2028 (USD Million)
    • 8.3. North America
      • 8.3.1 North America Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)
        • 8.3.1.1 North America Brain Tumor Diagnosis and Treatment Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 North America Brain Tumor Diagnosis and Treatment Market, by Diagnosis Type, 2022 - 2028
      • 8.4.1 North America Brain Tumor Diagnosis and Treatment Market, by Diagnosis Type, 2022 - 2028 (USD Million)
    • 8.5 North America Brain Tumor Diagnosis and Treatment Market, by Treatment Type, 2022 - 2028
      • 8.5.1 North America Brain Tumor Diagnosis and Treatment Market, by Treatment Type, 2022 - 2028 (USD Million)
    • 8.6 North America Brain Tumor Diagnosis and Treatment Market, by Product Type, 2022 - 2028
      • 8.6.1 North America Brain Tumor Diagnosis and Treatment Market, by Product Type, 2022 - 2028 (USD Million)
    • 8.4. Europe
      • 8.4.2 Europe Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)
        • 8.4.2.1 Europe Brain Tumor Diagnosis and Treatment Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 Europe Brain Tumor Diagnosis and Treatment Market, by Diagnosis Type, 2022 - 2028
      • 8.4.1 Europe Brain Tumor Diagnosis and Treatment Market, by Diagnosis Type, 2022 - 2028 (USD Million)
    • 8.5 Europe Brain Tumor Diagnosis and Treatment Market, by Treatment Type, 2022 - 2028
      • 8.5.1 Europe Brain Tumor Diagnosis and Treatment Market, by Treatment Type, 2022 - 2028 (USD Million)
    • 8.6 Europe Brain Tumor Diagnosis and Treatment Market, by Product Type, 2022 - 2028
      • 8.6.1 Europe Brain Tumor Diagnosis and Treatment Market, by Product Type, 2022 - 2028 (USD Million)
    • 8.5. Asia Pacific
      • 8.5.3 Asia Pacific Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)
        • 8.5.3.1 Asia Pacific Brain Tumor Diagnosis and Treatment Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 Asia Pacific Brain Tumor Diagnosis and Treatment Market, by Diagnosis Type, 2022 - 2028
      • 8.4.1 Asia Pacific Brain Tumor Diagnosis and Treatment Market, by Diagnosis Type, 2022 - 2028 (USD Million)
    • 8.5 Asia Pacific Brain Tumor Diagnosis and Treatment Market, by Treatment Type, 2022 - 2028
      • 8.5.1 Asia Pacific Brain Tumor Diagnosis and Treatment Market, by Treatment Type, 2022 - 2028 (USD Million)
    • 8.6 Asia Pacific Brain Tumor Diagnosis and Treatment Market, by Product Type, 2022 - 2028
      • 8.6.1 Asia Pacific Brain Tumor Diagnosis and Treatment Market, by Product Type, 2022 - 2028 (USD Million)
    • 8.6. Latin America
      • 8.6.4 Latin America Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)
        • 8.6.4.1 Latin America Brain Tumor Diagnosis and Treatment Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 Latin America Brain Tumor Diagnosis and Treatment Market, by Diagnosis Type, 2022 - 2028
      • 8.4.1 Latin America Brain Tumor Diagnosis and Treatment Market, by Diagnosis Type, 2022 - 2028 (USD Million)
    • 8.5 Latin America Brain Tumor Diagnosis and Treatment Market, by Treatment Type, 2022 - 2028
      • 8.5.1 Latin America Brain Tumor Diagnosis and Treatment Market, by Treatment Type, 2022 - 2028 (USD Million)
    • 8.6 Latin America Brain Tumor Diagnosis and Treatment Market, by Product Type, 2022 - 2028
      • 8.6.1 Latin America Brain Tumor Diagnosis and Treatment Market, by Product Type, 2022 - 2028 (USD Million)
    • 8.7. The Middle-East and Africa
      • 8.7.5 The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)
        • 8.7.5.1 The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market, by Diagnosis Type, 2022 - 2028
      • 8.4.1 The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market, by Diagnosis Type, 2022 - 2028 (USD Million)
    • 8.5 The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market, by Treatment Type, 2022 - 2028
      • 8.5.1 The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market, by Treatment Type, 2022 - 2028 (USD Million)
    • 8.6 The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market, by Product Type, 2022 - 2028
      • 8.6.1 The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market, by Product Type, 2022 - 2028 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1 GE Healthcare, Merck & Co. Inc., AstraZeneca, Carestream Health, Philips Healthcare, Siemens Healthcare Private Limited, Shimadzu Corporation, Hitachi Medical Systems, Pfizer.Inc, Toshiba Medical Systems.
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Brain Tumor Diagnosis and Treatment Market attractiveness, By Diagnosis Type
  • 6. Global Brain Tumor Diagnosis and Treatment Market attractiveness, By Treatment Type
  • 7. Global Brain Tumor Diagnosis and Treatment Market attractiveness, By Product Type
  • 8. Global Brain Tumor Diagnosis and Treatment Market share by Diagnosis Type, 2022 and 2028 (USD Million)
  • 9. Global Brain Tumor Diagnosis and Treatment Market by MRI, 2022 - 2028 (USD Million)
  • 10. Global Brain Tumor Diagnosis and Treatment Market by CT Scan, 2022 - 2028 (USD Million)
  • 11. Global Brain Tumor Diagnosis and Treatment Market by PET-CT Scan, 2022 - 2028 (USD Million)
  • 12. Global Brain Tumor Diagnosis and Treatment Market by EEG, 2022 - 2028 (USD Million)
  • 13. Global Brain Tumor Diagnosis and Treatment Market by Molecular Testing, 2022 - 2028 (USD Million)
  • 14. Global Brain Tumor Diagnosis and Treatment Market by Others, 2022 - 2028 (USD Million)
  • 15. Global Brain Tumor Diagnosis and Treatment Market share by Treatment Type, 2022 and 2028 (USD Million)
  • 16. Global Brain Tumor Diagnosis and Treatment Market by Surgery, 2022 - 2028 (USD Million)
  • 17. Global Brain Tumor Diagnosis and Treatment Market by Radiation Therapy, 2022 - 2028 (USD Million)
  • 18. Global Brain Tumor Diagnosis and Treatment Market by Radiosurgery, 2022 - 2028 (USD Million)
  • 19. Global Brain Tumor Diagnosis and Treatment Market by Chemotherapy, 2022 - 2028 (USD Million)
  • 20. Global Brain Tumor Diagnosis and Treatment Market by Targeted Drug Therapy, 2022 - 2028 (USD Million)
  • 21. Global Brain Tumor Diagnosis and Treatment Market by Immunotherapy, 2022 - 2028 (USD Million)
  • 22. Global Brain Tumor Diagnosis and Treatment Market share by Product Type, 2022 and 2028 (USD Million)
  • 23. Global Brain Tumor Diagnosis and Treatment Market by Primary Brain Tumor, 2022 - 2028 (USD Million)
  • 24. Global Brain Tumor Diagnosis and Treatment Market by Secondary Brain Tumor, 2022 - 2028 (USD Million)
  • 25. Global Brain Tumor Diagnosis and Treatment Market share, by Region, 2022 and 2028
  • 26. North America Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)
  • 27. Europe Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)
  • 28. Asia Pacific Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)
  • 29. Latin America Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)
  • 30. The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Brain Tumor Diagnosis and Treatment Market: Snapshot
  • 2. Drivers of the Brain Tumor Diagnosis and Treatment Market: impact analysis
  • 3. North America Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 4. North America Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 5. North America Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 6. U.S. Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 7. U.S. Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 8. U.S. Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 9. Canada Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 10. Canada Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 11. Canada Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 12. Europe Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 13. Europe Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 14. Europe Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 15. Germany Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 16. Germany Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 17. Germany Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 18. France Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 19. France Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 20. France Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 21. U.K. Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 22. U.K. Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 23. U.K. Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 24. Italy Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 25. Italy Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 26. Italy Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 27. Spain Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 28. Spain Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 29. Spain Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 30. Rest of Europe Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 31. Rest of Europe Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 32. Rest of Europe Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 33. Asia Pacific Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 34. Asia Pacific Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 35. Asia Pacific Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 36. China Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 37. China Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 38. China Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 39. Japan Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 40. Japan Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 41. Japan Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 42. India Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 43. India Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 44. India Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 45. South Korea Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 46. South Korea Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 47. South Korea Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 48. South-East Asia Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 49. South-East Asia Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 50. South-East Asia Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 51. Rest of Asia Pacific Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 52. Rest of Asia Pacific Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 53. Rest of Asia Pacific Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 54. Latin America Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 55. Latin America Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 56. Latin America Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 57. Brazil Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 58. Brazil Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 59. Brazil Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 60. Mexico Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 61. Mexico Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 62. Mexico Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 63. Rest of Latin America Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 64. Rest of Latin America Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 65. Rest of Latin America Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 66. The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 67. The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 68. The Middle-East and Africa Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 69. GCC Countries Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 70. GCC Countries Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 71. GCC Countries Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 72. South Africa Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 73. South Africa Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 74. South Africa Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)
  • 75. Rest of Middle-East Africa Brain Tumor Diagnosis and Treatment Market revenue, By Diagnosis Type, 2022 - 2028 (USD Million)
  • 76. Rest of Middle-East Africa Brain Tumor Diagnosis and Treatment Market revenue, By Treatment Type, 2022 - 2028 (USD Million)
  • 77. Rest of Middle-East Africa Brain Tumor Diagnosis and Treatment Market revenue, By Product Type, 2022 - 2028 (USD Million)

Methodology

Free Analysis

The brain is the most important organ of the human body, which consists of nerve cells and other supportive tissues. The development of cancerous cells in the brain is known as a brain tumor. There are two major types of brain tumor, namely secondary brain tumor and primary brain tumor. Primary brain tumors can either be malignant or benign, whereas secondary brain tumors are metastatic, i.e., they can spread to other organs as well.

According to CBTRUS (Central Brain Tumor Registry of the United States), in 2016, 80,000 new cases of nonmalignant, primary malignant, and CNS cancers were anticipated to be diagnosed in the U.S. in 2017. The rising incidence of brain tumor among the population is primarily fueling the growth of the global market for brain tumor diagnosis and treatment. The increasing geriatric population, development in diagnostics and treatment equipment, and ongoing research in the development of new technologies to treat cancers are anticipated to fuel the growth of the global brain tumor diagnosis and treatment market in the near future.

Global Brain Tumor Diagnosis and Treatment Market

The brain tumor diagnosis and treatment market are segmented based on product type, diagnosis type, and treatment type. Based on product type, the market for brain tumor diagnosis and treatment is bifurcated into primary brain tumor and secondary brain tumor. Primary brain tumors are further sub-segmented into gliomas, meningioma, pituitary tumors, astrocytomas, and other primary brain tumors. The primary brain tumor segment is anticipated to dominate the market during the forecast period, owing to the increase in the occurrences of meningioma cancer. Based on diagnosis type, this market is classified into MRI, CT scan, PET-CT scan, EEG, molecular testing, and others. The CT scan segment is anticipated to lead the diagnosis type segment for this market. The treatment type segment of the brain tumor diagnosis and treatment market includes chemotherapy, radiation therapy, targeted therapy, surgery, and immunotherapy. The surgery segment is estimated to dominate the brain tumor diagnosis and treatment market during the forecast period.

North America is projected to dominate the market during the forecast period, due to a rapid increase in research related to the development of techniques to treat brain tumor and increase in awareness about the treatments and management of brain tumor among the population. Europe is expected to show the highest growth owing to the rise in government initiatives, an increase in the prevalence of brain tumors in countries like the UK, and the growth of the geriatric population. Additionally, the growing awareness about brain tumor treatments and an increase in the investments made by companies are other factors fueling the growth of the brain tumor diagnosis and treatment market.

The main players in the brain tumor diagnosis and treatment market are GE Healthcare, Merck & Co. Inc., AstraZeneca, Hitachi Medical Corporation, Carestream Health, Pfizer, Inc., Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, and Shimadzu Corporation. These companies focus on entering agreements and partnership to develop products and provide quality products. For instance, in 2016, Pfizer Inc. acquired Medivation, a company which is involved in the development of drugs used for treating cancer.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The growing geriatric population and increased prevalence of brain tumors are significant factors driving the global growth of the brain tumor diagnosis and treatment market. Additionally, the increasing number of technical developments, as well as rising levels of investment in research and development activities, would contribute to the expansion of the brain tumor diagnosis and treatment market during the anticipated period.

According to the Market Research report, the Brain Tumor Diagnosis and Treatment Market was worth about 1,395.7 (USD million) in 2021 and is predicted to grow to around 2,036.5 (USD million) by 2028, with a compound annual growth rate (CAGR) of around 6.5 percent.

The market for brain tumor diagnostics and therapy is dominated by North America. This region's dominance in this market can be attributed to the greater diagnostic rate of malignancies such as glioblastoma in the United States. Greater access to advanced therapy is also expected to contribute to the region's supremacy.

Some of the main competitors dominating the Brain Tumor Diagnosis and Treatment Market include - GE Healthcare, Merck & Co., Inc., AstraZeneca, Carestream Health, Philips Healthcare, Siemens Healthcare Private Limited, Shimadzu Corporation, Hitachi Medical Systems, Pfizer.Inc, and Toshiba Medical Systems.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed